Project Grant R41DA051094

This Cooperative Agreement award of $150,000.00 from the Office of the National Drug Control Policy (ONDCP) under the Research and Data Analysis federal grant program (CFDA 95.007) will support the University of Maryland, College Park in developing an Emergency Department Substance Use Surveillance System. The project aims to conduct research and data analysis to inform drug policy formulation and assessment, with a focus on investigating substance use trends, overdose prevention strategies, and...

This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...

This $299,801 Cooperative Agreement award was provided by the Executive Office of the President's Office of the National Drug Control Policy (ONDCP) under the Research and Data Analysis Federal Grant Program (CFDA 95.007). The award is focused on conducting research and data analysis related to wastewater drug indicators on the U.S. Southern border. Key products and services to be delivered include: Wastewater sampling and analysis across multiple locations in southern Arizona, with sample...

The National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems awarded a $399,541 Project Grant to the Trustees of Dartmouth College to develop a high-throughput, label-free, and portable sensor that can quantitatively detect multiple illicit drugs including opioids, cocaine, psychostimulants, and methadone in liquid samples such as biofluids. The project aims to create a silver or gold nanoparticle-decorated zinc oxide nanorod coated silica nanofiber matrix...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $688,271 to Yale University to conduct a comprehensive research project examining the spatial and temporal variability in a state's illicit drug market. The key products and services to be delivered under this 5-year grant, which runs from June 1, 2025 to February 28, 2030, include: 1) Expanding existing street-based testing of drug samples...

Under this U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Small Business Innovation Research (SBIR) Phase 2 project, Ondavia, Inc. is developing, prototyping, validating, and commercializing an in-line, automated, semi-continuous instrument to monitor and measure the nitrogen cycle in water using Surface-Enhanced Raman Spectroscopy (SERS). The $600,000 award supports the assembly and testing of a prototype analyzer for automated, quantitative analysis...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $306,872 to Xcellassay, Inc., a biotechnology research firm in San Francisco, California. The funding supports the validation of a novel bioassay platform to identify individuals, particularly youth athletes, using anabolic androgenic steroids (AAS), which are Schedule III controlled substances with high rates of illicit use. The proposed...

This $523,608 federal Project Grant award from the National Oceanic and Atmospheric Administration's (NOAA) Small Business Innovation Research (SBIR) Program, CFDA 11.021, supports the development of Rapid Radicals Technology's patent-pending catalytically enhanced advanced oxidation process for municipal wastewater treatment. The funding will enable two key technical milestones: (1) determining the feasibility of applying a scalable catalyst to decrease treatment time and improve energy...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop and evaluate a customized version of the "MyTrials" remote biomarker capture system for use in decentralized clinical trials (DCTs) for substance use disorders (SUDs). The key products and services to be delivered include: 1) Refinement of the existing MyTrials prototype to support the...

This $100,000 Project Grant award from the National Science Foundation (NSF) Social, Behavioral, and Economic Sciences (SBE) program (CFDA 47.075) aims to integrate wastewater surveillance and human behavior data to enhance epidemiological modeling and outbreak detection. The principal investigators at Lawrence Technological University will pursue three main objectives: (1) developing an early-warning system using wastewater and digital/social behavior data, (2) creating a...